Integrated list of glycoproteins extracted from UniProt and annotated with glycosylation data from GlyGen, GlyConnect, GlycoProtDB and The O-GlcNAc Database. For each entry, information such as glycosylation site, glycans, diseases, 3D structures, and pathway information are available.
Source | Last Updated |
---|---|
GlyConnect | April 19, 2023 |
GlycoProtDB | October 1, 2021 |
GlyGen | June 4, 2024 |
The O-GlcNAc Database | June 3, 2024 |
UniProt | June 4, 2024 |
UniProt ID ▲ | Protein Name | Gene Symbol | Organism | No. of Glycosylation Sites | No. of GlyTouCan IDs | Disease Ontology |
---|---|---|---|---|---|---|
F6UN48 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase |
|
Equus caballus (horse) | 1 | 0 |
|
F6V1J4 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase |
|
Equus caballus (horse) | 1 | 0 |
|
F6V9L3 | Angiotensin-converting enzyme |
|
Equus caballus (horse) | 7 | 0 |
|
F6WFF6 | Tartrate-resistant acid phosphatase type 5 |
|
Equus caballus (horse) | 1 | 0 |
|
F6WMB5 | Pannexin |
|
Equus caballus (horse) | 1 | 0 |
|
F6WV32 | Proto-oncogene tyrosine-protein kinase receptor Ret |
|
Equus caballus (horse) | 1 | 0 |
|
F6X1I8 | Hemopexin |
|
Equus caballus (horse) | 1 | 0 |
|
F6XJJ5 | P2X purinoceptor |
|
Equus caballus (horse) | 1 | 0 |
|
F6XSW1 | P2X purinoceptor |
|
Equus caballus (horse) | 1 | 0 |
|
F6XW20 | Phosphoinositide phospholipase C |
|
Equus caballus (horse) | 2 | 0 |
|
F6Y366 | N-acetylgalactosamine-6-sulfatase |
|
Equus caballus (horse) | 2 | 0 |
|
F6Y9V9 | Voltage-dependent L-type calcium channel subunit alpha |
|
Equus caballus (horse) | 1 | 0 |
|
F6YCQ8 | Potassium channel subfamily K member |
|
Equus caballus (horse) | 1 | 0 |
|
F6YFB7 | Voltage-dependent L-type calcium channel subunit alpha |
|
Equus caballus (horse) | 1 | 0 |
|
F6YFJ5 | Voltage-dependent L-type calcium channel subunit alpha |
|
Equus caballus (horse) | 1 | 0 |
|
F6YI82 | P2X purinoceptor |
|
Equus caballus (horse) | 1 | 0 |
|
F6YLN3 | ADAM metallopeptidase with thrombospondin type 1 motif 1 |
|
Equus caballus (horse) | 3 | 0 |
|
F6ZEZ2 | Protein adenylyltransferase FICD |
|
Equus caballus (horse) | 1 | 0 |
|
F6ZSR4 | Angiotensin-converting enzyme |
|
Equus caballus (horse) | 7 | 0 |
|
F7ABU3 | N-acylethanolamine-hydrolyzing acid amidase |
|
Equus caballus (horse) | 4 | 0 |
|
F7ACI3 | ADAM metallopeptidase with thrombospondin type 1 motif 5 |
|
Equus caballus (horse) | 2 | 0 |
|
F7AG73 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase |
|
Equus caballus (horse) | 1 | 0 |
|
F7AIE6 | Voltage-dependent L-type calcium channel subunit alpha |
|
Equus caballus (horse) | 1 | 0 |
|
F7B5T3 | Hyaluronidase |
|
Equus caballus (horse) | 1 | 0 |
|
F7B7I5 | Rhodopsin |
|
Equus caballus (horse) | 2 | 0 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024